Загрузка...
Comparison of two adjuvant hormone therapy regimens in patients with high-risk localized prostate cancer after radical prostatectomy: primary results of study CU1005
The role of adjuvant hormonal therapy and optimized regimens for high-risk localized prostate cancer after radical prostatectomy remains controversial. Herein, the clinical trial CU1005 prospectively evaluated two regimens of maximum androgen blockage or bicalutamide 150 mg daily as immediate adjuva...
Сохранить в:
| Опубликовано в: : | Asian J Androl |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Medknow Publications & Media Pvt Ltd
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4854103/ https://ncbi.nlm.nih.gov/pubmed/26323560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1008-682X.160884 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|